Co., Ltd., F
Edison P, Femminella GD, Ritchie C, Nowell J, Holmes C, Walker Z, et al
Kidney caution Limited information is available regarding using Astaxanthin+l Glutathione+lutein in patients suffering from kidney impairment
It is administered as a once-weekly subcutaneous injection following a structured dose-escalation schedule, typically starting at 2 mg and increasing to 812 mg weekly in Phase 2 protocols
After 4 months of glutathione treatment, ALT levels decreased significantly
Since 2016, Aspergillus fumigatus (associated with a mortality rate of 50%90%), Cryptococcus neoformans (20%70%), and Candida albicans (20%40%) have been recognized as the leading causes of life-threatening fungal infections (Vandeputte et al., 2012